发明名称 |
DNA vaccine enhancement with MHC class II activators |
摘要 |
Methods for treating or preventing hyperproliferating diseases, e.g., cancer, are described. A method may comprise administering to a subject in need thereof a therapeutically effective amount of a nucleic acid encoding an MHC class I and/or II activator and optionally a nucleic acid encoding an antigen. |
申请公布号 |
US9085638(B2) |
申请公布日期 |
2015.07.21 |
申请号 |
US200812043656 |
申请日期 |
2008.03.06 |
申请人 |
The Johns Hopkins University |
发明人 |
Wu Tzyy-Choou;Hung Chien-Fu |
分类号 |
A61K39/00;A61K39/395;C07H21/00;C07K14/47;A61K39/39 |
主分类号 |
A61K39/00 |
代理机构 |
Foley Hoag LLP |
代理人 |
Foley Hoag LLP |
主权项 |
1. A composition comprising a first nucleic acid encoding the amino acid sequence of a fusion protein as set forth in SEQ ID NO: 91, wherein the fusion protein stimulates a CD4+ immune response; and a second nucleic acid encoding an antigen, wherein the first nucleic acid enhances a CD8+ T cell immune response generated from the second nucleic acid. |
地址 |
Baltimore MD US |